Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMetro Bank Regulatory News (MTRO)

Share Price Information for Metro Bank (MTRO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.95
Bid: 31.85
Ask: 32.10
Change: -0.15 (-0.47%)
Spread: 0.25 (0.785%)
Open: 30.85
High: 33.00
Low: 30.85
Prev. Close: 32.10
MTRO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Metro Bank plc

18 Nov 2021 11:51

RNS Number : 8475S
Societe Generale SA
18 November 2021
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Société Générale S.A.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Metro Bank plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

17/11/2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3,681,951

2.14

10,504

0.00

(2) Cash-settled derivatives:

 

0

0.00

3,674,443

2.13

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

TOTAL:

3,681,951

2.14

3,684,947

2.14

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit GBP

Ordinary

Purchase

2,150

1.3

Ordinary

Purchase

1,073

1.3

Ordinary

Purchase

118

1.305

Ordinary

Sale

2,557

1.295

Ordinary

Sale

354

1.295

Ordinary

Sale

990

1.291

Ordinary

Sale

253

1.295

Ordinary

Sale

3,273

1.292

Ordinary

Sale

2,283

1.291

Ordinary

Sale

602

1.295

Ordinary

Sale

72

1.295

 

Total Purchases

3,341

 

 

Total Sales

10,384

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit GBP

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing, or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

GBP

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit GBP

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) GBP

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

18/11/2021

Contact name:

Paul Jenkins

Telephone number*:

+44 20 7676 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFLFELLILTLIL
Date   Source Headline
20th Mar 20202:57 pmRNSHolding(s) in Company
18th Mar 20203:38 pmRNSHolding(s) in Company
18th Mar 20203:19 pmRNSHolding(s) in Company
13th Mar 20204:33 pmRNSDirectorate Change
12th Mar 20202:58 pmRNSHolding(s) in Company
11th Mar 20203:44 pmRNSBlock listing Interim Review
6th Mar 20203:13 pmRNSHolding(s) in Company
3rd Mar 20203:27 pmRNSHolding(s) in Company
3rd Mar 20203:14 pmRNSHolding(s) in Company
2nd Mar 20203:32 pmRNSHolding(s) in Company
2nd Mar 20203:04 pmRNSTotal Voting Rights
28th Feb 20204:06 pmRNSHolding(s) in Company
26th Feb 20207:01 amRNSUpdate regarding Capability & Innovation funding
26th Feb 20207:00 amRNSResults for Year ended 31 December 2019
19th Feb 20207:00 amRNSMetro Bank appoints CEO
10th Feb 20203:41 pmRNSHolding(s) in Company
7th Feb 20204:41 pmRNSHolding(s) in Company
3rd Feb 20205:00 pmRNSTotal Voting Rights
2nd Jan 20204:12 pmRNSTotal Voting Rights
23rd Dec 20192:59 pmRNSDirectorate Change
17th Dec 20193:37 pmRNSMetro Bank Board Update
9th Dec 20193:07 pmRNSHolding(s) in Company
6th Dec 20193:12 pmRNSHolding(s) in Company
5th Dec 20193:01 pmRNSHolding(s) in Company
4th Dec 20194:50 pmRNSMetro Bank announces CEO to step down
4th Dec 20193:02 pmRNSHolding(s) in Company
2nd Dec 20195:52 pmRNSTotal Voting Rights
2nd Dec 20193:30 pmRNSHolding(s) in Company
29th Nov 20193:11 pmRNSHolding(s) in Company
27th Nov 20193:08 pmRNSHolding(s) in Company
26th Nov 20193:26 pmRNSHolding(s) in Company
26th Nov 20193:10 pmRNSHolding(s) in Company
21st Nov 20193:33 pmRNS2019 AGM Results - Update Statement
19th Nov 20195:16 pmRNSInterim Senior Independent Director Appointed
1st Nov 20194:57 pmRNSTotal Voting Rights
23rd Oct 20194:45 pmRNSQ3 Trading Update 2019
23rd Oct 20197:00 amRNSMetro Bank Board Update
4th Oct 20194:58 pmRNSPublication of Final Terms
2nd Oct 20194:26 pmRNSPublication of Supplementary Prospectus
2nd Oct 20194:13 pmRNSSuccessful pricing of £350m MREL debt issuance
2nd Oct 20192:00 pmRNSMetro Bank Updates on MREL Transaction
2nd Oct 201912:55 pmRNSMetro Bank Updates on MREL Transaction
2nd Oct 20197:37 amRNSMetro Bank Board Update
1st Oct 20195:09 pmRNSTotal Voting Rights
30th Sep 20196:15 pmRNSMetro Bank PLC Fitch Rating Review
27th Sep 20193:17 pmRNSHolding(s) in Company
24th Sep 20199:42 amRNSPostponed MREL debt issuance
20th Sep 20191:56 pmRNSHolding(s) in Company
18th Sep 201912:11 pmRNSDirector/PDMR Shareholding
17th Sep 20195:51 pmRNSPublication of a Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.